Literature DB >> 22614622

Acute coronary syndromes: Early metabolic modulation--a solution for MI?

Iwan C C van der Horst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22614622     DOI： 10.1038/nrcardio.2012.75

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report.

Authors:  D SODI-PALLARES; M R TESTELLI; B L FISHLEDER; A BISTENI; G A MEDRANO; C FRIEDLAND; A DE MICHELI
Journal:  Am J Cardiol       Date:  1962-02       Impact factor: 2.778

2.  Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial.

Authors:  C S Apstein; H Taegtmeyer
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

3.  Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.

Authors:  Harry P Selker; Joni R Beshansky; John L Griffith; Ralph B D'Agostino; Joseph M Massaro; James E Udelson; Eric J Rashba; Robin Ruthazer; Patricia R Sheehan; Patrice Desvigne-Nickens; Yves D Rosenberg; James M Atkins; Assaad J Sayah; Tom P Aufderheide; Charles E Rackley; Lionel H Opie; Costas T Lambrew; Leonard A Cobb; Bruce A Macleod; Joanne S Ingwall; Robert J Zalenski; Carl S Apstein
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

4.  Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.

Authors:  Jorik R Timmer; Miriam Hoekstra; Maarten W N Nijsten; Iwan C C van der Horst; Jan Paul Ottervanger; Robbert J Slingerland; Jan-Henk E Dambrink; Henk J G Bilo; Felix Zijlstra; Arnoud W J van 't Hof
Journal:  Circulation       Date:  2011-07-18       Impact factor: 29.690

5.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors:  Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal:  JAMA       Date:  2012-03-27       Impact factor: 56.272

6.  Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction.

Authors:  I C C van der Horst; J R Timmer; J-P Ottervanger; H J G Bilo; K Miedema; R O B Gans; M-J de Boer; M Vogelzang; M W N Nijsten; F Zijlstra
Journal:  Neth Heart J       Date:  2006-03       Impact factor: 2.380

7.  Tight glycemic control may increase regenerative potential of myocardium during acute infarction.

Authors:  Raffaele Marfella; Ferdinando Carlo Sasso; Federico Cacciapuoti; Michele Portoghese; Maria Rosaria Rizzo; Mario Siniscalchi; Ornella Carbonara; Franca Ferraraccio; Michele Torella; Antonello Petrella; Maria Luisa Balestrieri; Paola Stiuso; Giannantonio Nappi; Giuseppe Paolisso
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

Review 8.  Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.

Authors:  Abhinav Goyal; Kara Nerenberg; Hertzel C Gerstein; Guillermo Umpierrez; Peter W F Wilson
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

9.  The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616].

Authors:  Iwan C C van der Horst; Jan Paul Ottervanger; Arnoud W J van 't Hof; Stoffer Reiffers; Kor Miedema; Jan C A Hoorntje; Jan-Henk E Dambrink; A T Marcel Gosselink; Maarten W N Nijsten; Harry Suryapranata; Menko-Jan de Boer; Felix Zijlstra
Journal:  BMC Med       Date:  2005-06-02       Impact factor: 8.775
  9 in total
  3 in total

1.  Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.

Authors:  Satoshi Ito; Tomohisa Nagoshi; Kosuke Minai; Yusuke Kashiwagi; Hiroshi Sekiyama; Akira Yoshii; Haruka Kimura; Yasunori Inoue; Kazuo Ogawa; Toshikazu D Tanaka; Takayuki Ogawa; Makoto Kawai; Michihiro Yoshimura
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

2.  Collaborative Activities of Noradrenaline and Natriuretic Peptide for Glucose Utilization in Patients with Acute Coronary Syndrome.

Authors:  Goki Uno; Tomohisa Nagoshi; Akira Yoshii; Yasunori Inoue; Yoshiro Tanaka; Haruka Kimura; Satoshi Ito; Kazuo Ogawa; Toshikazu D Tanaka; Kosuke Minai; Takayuki Ogawa; Makoto Kawai; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

3.  Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

Authors:  Kun Zhao; Yue Zhang; Jia Li; Qin Cui; Rong Zhao; Wensheng Chen; Jincheng Liu; Bijun Zhao; Yi Wan; Xin-Liang Ma; Shiqiang Yu; Dinghua Yi; Feng Gao
Journal:  J Am Heart Assoc       Date:  2020-03-10       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.